Dr Emily Atkins

Dr Emily R Atkins is a Senior Research Fellow in Health Systems Science at the George Institute for Global Health and a Conjoint Senior Lecturer at UNSW Sydney. She has expertise in economic evaluation, cardiovascular trials, and linked data analysis. Dr Atkins' recent focus has been on the health economics of blood pressure lowering medicines. She is interested in affordable and equitable improvements in cardiovascular medicines use globally. Dr Atkins is the health economist leading the economic evaluation of the NEXTGEN-BP randomised trial.

Dr Atkins is an Executive Committee member and Scientific Advisory Committee member of the Australian and New Zealand Alliance for Cardiovascular Trials (2018-present). She was a National Heart Foundation Australia Postdoctoral Research Fellow (2018) and World Heart Federation Emerging Leader (2017) working on blood pressure lowering clinical trials and access and affordability of cardiovascular medicines, including a feasibility study of adherence clubs for hypertension.

Emily completed her PhD (2015) at the University of Western Australia using linked administrative hospital morbidity, deaths, and pharmacy data to investigate the cost-effectiveness of cardiovascular medicines for secondary prevention of atherothrombotic disease.